Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Pro-Pharmaceuticals to discuss Davanat NDA with FDA

Feb. 27, 2007

Xeloda recommended for E.U. approval for advanced gastric cancer

Feb. 26, 2007

Novel synthetic diazonamide A analogue shows promise in preclinical studies

Feb. 26, 2007

Peregrine licensee begins phase I trial with TNT cancer agent

Feb. 26, 2007

New phase I trial studies L-annamycin in pediatric ALL and AML

Feb. 26, 2007

Pharmacyclics receives refusal to file letter for Xcytrin

Feb. 23, 2007

Hybrigenics focuses research on USP inhibitors for cancer

Feb. 23, 2007

GPC Biotech launches satraplatin expanded access program

Feb. 23, 2007

Identification of active sites of Polo-like kinases useful for developing new cancer therapies

Feb. 23, 2007

Recent patents cover new therapeutic agents for cancer

Feb. 23, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...